HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by article Browse by volume    

Heroin Addiction and Related Clinical Problems: 2021, 23, N6 (pages: 33 - 39)

Overdose Risk and Attitudes to Take-Home Naloxone Among Opioid Users in Prague and London: A Survey Comparison

Sefranek M., McDonald R., Kelleher M., Breidahl S., Pavlidis P., Miovsky M., and Strang J.

Summary: Background Take-home naloxone (THN) programmes have been introduced in many European countries. In the Czech Republic, where the incidence of the opioid-overdose deaths is below the European average, THN is not available. We assessed a) drug use and overdose history and b) attitudes regarding THN among people who use opioids (PWUO) in Prague and compare these outcomes with a reference sample of PWUO in London, where THN is available. Methods This cross-sectional study was conducted in PWUO (age ≥18) attending three outpatient addiction clinics in Prague and one in London between April 2018 and June 2019. A purpose-developed questionnaire was administered in the local language. Results In total, n=125 PWUO completed the questionnaire, consisting of 60 participants in Prague (37/60; 62.7% male) and 65 in London (59/65; 90.8% male). The Prague sample primarily used (diverted) buprenorphine (37/60; 62.7%), with significantly higher rates of lifetime injecting use (60/60, 100.0%; vs. London: 46/65; 70.8%; p<0.001) and personal overdose (38/60; 63.3%; vs. London: 29/65; 44.6%; p=0.036). Most participants across both samples had witnessed overdoses (Prague: 43/60, 71.7%; London: 51/65, 78.5%; p = n.s.). PWUO in Prague wished to have a THN kit (44/60; 74.6%) and considered naloxone training to be “extremely” or “very” important (43/60; 74.1%). Conclusions PWUO in Prague are at least as likely to overdose themselves and witness opioid overdoses as their peers in London. They expressed strong interest in THN and opioid-overdose management training, suggesting that THN should be made available to Czech PWUO.

 

AU-CNS Associazione per l’Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali
Association for the Application of Neuroscientific Knowledge to Social Aims
Via XX Settembre, 83 – 55045 PIETRASANTA (Lucca) - Italy
P. IVA 01681650469 – Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page